Lawsuit challenges EviCore's decision to restrict low-dose radiation treatments
Radiation oncologists and medical physicists have filed a lawsuit challenging EviCore's decision to sharply restrict coverage of low-dose radiation therapy for several benign conditions, including osteoarthritis and plantar fasciitis.
EviCore, a Franklin, Tennessee-based medical benefits management company, reviews treatment requests on behalf of health plans, including Blue Cross, Aetna and Cigna (its parent company). Previously, its coverage guidelines allowed RT for osteoarthritis and plantar fasciitis, a decision in place since around 2019.
As recently as February, EviCore described low-dose radiation therapy as medically necessary for certain conditions, citing a response rate approaching 80% and an efficacy duration of around 11 months. Under those criteria, patients with arthritis, bursitis, tendonitis or plantar fasciitis could qualify for treatment with low-dose RT.
However, those guidelines were recently revised. The new updates, which took effect Nov. 5, classify low-dose radiation therapy as not medically necessary for nearly all conditions previously covered, with an exception for tennis elbow. EviCore cited a “paucity of evidence” supporting the treatment, according to physicians.
This prompted the Radiotherapy Access Alliance to file a suit Nov. 4 in Orange County Circuit Court seeking a ruling on the parties' rights under Florida law. The nonprofit alleges that EviCore's new policy interferes with the relationship between physicians and their patients in reaching treatment-related decisions. The alliance is not seeking monetary damages.
Evan Thomas, MD, PhD, a radiation oncologist in Winter Park, Florida, and president of the alliance, said the group and other organizations have attempted to engage EviCore before turning to litigation, but their efforts were ineffective.
The Radiotherapy Access Alliance was founded in August and includes radiation oncologists and physicists from multiple states. It advocates for fair coverage of radiation therapy. The lawsuit and request for an injunction represent the group's latest effort to preserve access to low-dose radiation therapy under the previous criteria while the legal dispute is resolved.
Read more here.
